AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06695624 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sphenopalatine Ganglion Block
Description: Sphenopalatine ganglion block group 4cc (80mg) 2% lidocaine + 1cc (4mg) dexamethasone in total 5cc volume will be prepared under sterile conditions before the procedure, 2.5 cc will be given to both nostrils. Sphenopalatine ganglion block will be applied by transnasal endoscopic method.
Study NCT06688643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ITM group
Description: Patients in the ITM group underwent intrathecal injection with 0.2 mg morphine after admission to the operating room.Mechanical ventilation was initiated in pressure-regulated volume control (PRVC) mode after induction. Ventilator settings (Aestiva; GE Healthcare, Waukesha, Wisconsin, USA) were as follows: tidal volume 6-8 ml kg-1, positive end-expiratory pressure (PEEP) 0 cmH2O, inspiratory-to-expiratory ratio 1:2, respiratory rate 16 beats per minute (BPM), and inspired oxygen concentration 41%.
Study NCT06688643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EA group
Description: Patients in the EA group underwent epidural anesthesia after admission to the operating room. Following successful epidural puncture, 3 ml of 2% lidocaine was administered. Once the block level was confirmed, the epidural analgesia pump was activated, delivering 8 ml/h of 0.1% ropivacaine.Mechanical ventilation was initiated in pressure-regulated volume control (PRVC) mode after induction. Ventilator settings (Aestiva; GE Healthcare, Waukesha, Wisconsin, USA) were as follows: tidal volume 6-8 ml kg-1, positive end-expiratory pressure (PEEP) 0 cmH2O, inspiratory-to-expiratory ratio 1:2, respiratory rate 16 beats per minute (BPM), and inspired oxygen concentration 41%.
Study NCT06695000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital CBT-I
Description: The intervention is a digital Cognitive Behavioral Therapy for Insomnia (CBT-I) program, delivered via a mobile application. The program includes structured, self-guided modules focusing on sleep hygiene education, cognitive restructuring, stimulus control, bed time restriction, and relaxation techniques. Each module offers interactive exercises and weekly assignments designed to support behavior change and improve sleep. Participants will receive app-based reminders to encourage regular engagement, with features for tracking progress and adherence throughout the 6 week program.
Study NCT06689254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone 1200 mg daily
Description: Oral tablets
Study NCT06689254 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablet
Study NCT06687408 — intervention group
Intervention type: PROCEDURE
Intervention: RATS Group
Description: The participants with centrally located lung cancer in this group were performed sleeve lobectomy in robotic-assisted thoracic surgery (RATS) approach, which has been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently.
Study NCT06687408 — intervention group
Intervention type: PROCEDURE
Intervention: VATS group
Description: The participants with centrally located lung cancer in this group were performed sleeve lobectomy in video-assisted thoracic surgery (VATS) approach.
Study NCT06689358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.4 ml/kg of 0.5% bupivacaine
Description: 0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
Study NCT06686758 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sugar cane polysaccharide
Description: Sugar cane polysaccharide
Study NCT06686758 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: placebo
Study NCT06690515 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A
Description: 0,5 ml DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A injected three-dose regimen with 28 days interval between doses. Vaccine is injected intramuscularly in left anterolateral thigh.
Study NCT06690515 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B
Description: 0,5 ml injected of DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B three-dose regimen with 28 days interval between doses. Injected intramuscularly in left anterolateral thigh.
Study NCT06690515 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)®
Description: The control group will receive 0,5 ml of Registered DTwP-Hepatitis B-Hib vaccine and 0,5 ml IPV (Sinovac)® injected in three-dose regimen with 28 days interval between doses. Registered DTwP-Hepatitis B-Hib Vaccine are injected intramuscularly into the left antero-lateral thigh region. IPV (Sinovac)® vaccine are injected intramuscularly into the right mid-lateral thigh region
Study NCT06691009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Group 1 (mechanical pleurodesis)
Description: pleural abrasions will be done by scrubbing the parietal and visceral pleura until a uniform aspect of bloody pleura by a piece of gauze attached to the end of a holding forceps , intercostal tube will then placed and monitoring of lung expansion will be done through serial CXR and chest ultrasound follow up and when the lung is fully expanded the tube will be clamped for two hours and follow up CXR will be done for follow up and then the tube removed
Study NCT06691009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Group 2 chemical pleurodesis by bleomycin)
Description: Those Patients will have indwelling pleural catheter through which pleural fluid will be drained until dryness and then pleurodesis will be done by 60 mg bleomycin dissolved in 50 ml 0.9% saline and 10 ml 2% xylocaine solution then the catheter will be clamped for 6 hours
Study NCT06690957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 68Ga/18F-TATE/JR11/LM3
Description: Each subject receive a single intravenous injection of 68Ga/18F-TATE/JR11/LM3, and undergo PET/CT imaging within the specificed time.
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MB12 (Proposed Pembrolizumab Biosimilar)
Description: 200mg IV, every 3 weeks on Day 1
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EU-sourced Keytruda®
Description: 200mg IV, every 3 weeks on Day 1
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: US-sourced Keytruda®
Description: 200mg IV, every 3 weeks on Day 1
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: 500 mg/m2 IV, every 3 weeks on Day 1
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: 500 mg/m2 IV, every 3 weeks on Day 1
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Area under the curve (AUC) 5 IV, every 3 weeks on Day 1 for 4 cycles.
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Area under the curve (AUC) 5 IV, every 3 weeks on Day 1 for 4 cycles.
Study NCT06114108 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
Description: The choice of LAT intervention for the primary tumor and all metastases (surgery or SBRT) and the sequence of the treatment (primary tumor vs metastases) will be decided at the local MDT according to the medical need and patient counseling during interdisciplinary clinic visits.
Study NCT06114108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
Description: The choice of LAT intervention for the primary tumor and all metastases (surgery or SBRT) and the sequence of the treatment (primary tumor vs metastases) will be decided at the local MDT according to the medical need and patient counseling during interdisciplinary clinic visits.
Study NCT06114108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Surgery
Study NCT06114108 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: Radiotherapy
Study NCT06114108 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Radiotherapy
Study NCT05214378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Finetech-Brindley Sacral Anterior Roots Stimulation System
Description: Electrodes implanted on sacral roots connected to implanted induction coil. External controller box administers stimulation via induction through skin to electrodes. Stimulation activates nerves to modulate bladder, bowel, and sexual functions.
Study NCT04743518 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aortic pulse wave velocity
Description: Aortic pulse wave velocity (aPWV) is a measure of aortic stiffness
Study NCT04743518 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: carotid intima media thickness (CIMT)
Description: carotid intima media thickness (CIMT)
Study NCT06480669 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time Restricted Feeding
Description: 8 participants who practiced a 12/12 TRF (12 hours of fasting, from approximately 20:30 to 8:30 the following day).
Study NCT06480669 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean Diet
Description: A control group consisting of 9 participants who followed a standard Mediterranean diet.
Study NCT05154747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabotegravir, Rilpivirine Drug Combination
Description: Cabotegravir LA 600mg as a 3mL IM injection. The product is packaged in a 3mL USP Type I glass vial. Each vial is for single-dose use. CAB LA injectable suspension is to be stored according to the product label at room temperature (\<30oC). CAB LA is composed of cabotegravir free acid, polysorbate 20, polyethylene glycol3350, mannitol, and water for injection.~Rilpivirine LA 900mg as a 3mL IM injection. Each single-dose vial contains 900mg/3mL rilpivirine. RPV LA injectable suspension should be stored according to the product label refrigerated at 2-8oC and should be protected from light. RPV LA is composed of RPV free base, poloxamer 338, sodium dihydrogen phosphate monohydrate, citric acid monohydrate, glucose monohydrate, sodium hydroxide, and water for injection.~Cabotegravir Long-Acting (CAB LA) will be given IM into one buttock, and Rilpivirine Long-Acting (RPV LA) will be given IM into the opposite buttock.
Study NCT05154747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TLD
Description: Dolutegravir 50mg oral with tenofovir disoproxil fumarate (245mg) and lamivudine (300mg) in a fixed dose combination or Dolutegravir 50mg oral with tenofovir alafenamide fumarate (25mg) and lamivudine (300mg) (l/TAF) oral in a fixed dose combination
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: 75 mg/m2 IV, every 3 weeks on Day 1 for 4 cycles
Study NCT05339464 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Family Wellness program
Description: Weekly one-hour online workshops over an 8 week period. Families will also receive text message reminders as part of the intervention.
Study NCT05146024 — intervention group
Intervention type: BEHAVIORAL
Intervention: Way To Serve Plus: Improving Responsible Alcohol Service
Description: Improving responsible alcohol service of owners, managers, and employees of alcohol-serving establishments by developing professional development components to enhance their responsible beverage service skills.
Study NCT05556005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trimetazidine Dihydrochloride
Description: Trimetazidine Dihydrochloride 35 mg modified release tablet used twice daily
Study NCT05556005 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Starch tablets used twice daily
Study NCT05951153 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Tributyrin
Description: Tributyrin is a nutritional supplement prepared by esterification of glycerin with butyric acid that promotes delivery of free butyrate to distal portions of the gut.
Study NCT06687369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 75 mg/m2 IV, every 3 weeks on Day 1 for 4 cycles
Study NCT06686550 — intervention group
Intervention type: OTHER
Intervention: This is a observational study and there is no intervention.
Description: This is a observational study and there is no intervention.
Study NCT06688526 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quiet Sounds
Description: Quiet sounds are played during sleep
Study NCT06688526 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham sounds
Description: No sounds are played during sleep
Study NCT06687486 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: relaxin
Description: caregivers relaxing and care burden
Study NCT06687486 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: kontrol
Description: no intervention
Study NCT06691139 — intervention group
Intervention type: PROCEDURE
Intervention: Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years
Description: Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia
Study NCT06691139 — intervention group
Intervention type: OTHER
Intervention: Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft
Description: Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft
Study NCT06691139 — intervention group
Intervention type: PROCEDURE
Intervention: Myringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft
Description: Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years
Study NCT06691139 — intervention group
Intervention type: PROCEDURE
Intervention: Group (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft
Description: Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years
Study NCT06686290 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-Isometric Relaxation Technique
Description: Post isometric relaxation will be performed with the frequency of 5 times, such that it includes 30 isometric contraction of the muscle to be stretched for 10 seconds, followed by rest period of 5 seconds and then a stretch of 10 seconds hold.
Study NCT06686290 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static Stretching
Description: Static Stretching
Study NCT06686277 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gong's Mobilization Technique
Description: The therapist will push the scapula of the affected side in a posterior to anterior direction with one hand, and pushed the humeral head in an anterior to posterior direction parallel to joint plane with the other hand.
Study NCT06686277 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization Technique
Description: Mulligan Mobilization Technique
Study NCT06691425 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: SBRT (5 x 8 Gy)
Study NCT06691425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Standard of care: mFOLFIRINOX or gemcitabine/nab-paclitaxel
Study NCT06691425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Standard of care: mFOLFIRINOX or gemcitabine/nab-paclitaxel
Study NCT06688097 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Compression of esophageal
Description: Before the start of FMV, ultrasound is used to locate the esophagus, and pressure is applied to the esophagus at the cricoid level to collapse the esophageal lumen. Esophageal pressure is released just before tracheal intubation following 4 minutes of ventilation.
Study NCT05476848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ELISA test for Cytokines
Description: ELISA tests specific for cytokines (IL-1, IL-6, IL-10) and immunoglobulins (IgA, IgG, IgM) will be performed by a biochemistry lab, both for blood samples and oral swap samples.
Study NCT05476848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ELISA test for Cytokines
Description: ELISA tests specific for cytokines (IL-1, IL-6, IL-10) and immunoglobulins (IgA, IgG, IgM) will be performed by a biochemistry lab, both for blood samples and oral swap samples.
Study NCT04810858 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Multimodal, multi-parametric MRI
Description: The investigators will use multimodal, multi-parametric sequences to investigate neuroinflammatory and neurodegenerative processes in vivo. Participants will be assessed three times over 2 years.
Study NCT04810858 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Immune and cytokine profiling
Description: Blood samples will be collected for immune and cytokine profiling. Participants will be assessed three times over 2 years.
Study NCT04810858 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neuropsychological testing
Description: Participants will have neuropsychological testing three times over 2 years.
Study NCT05833945 — intervention group
Intervention type: DEVICE
Intervention: Large Vessel Occlusion Biomarkers Test
Description: Duplex Point of Care test to measure the concentration of biomarkers associated to Large Vessel Occlusion in blood samples used in combination with an APP.
Study NCT05956392 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screen-use reduction + Sleep extension
Description: 60 minutes of a participants' daily screen-use time on school days will be repurposed for more sleep time.
Study NCT05837247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Game-based telerehabilitation exercises
Description: online Game-based home exercises are physiotherapy programs that include exercises transformed into game activities to increase the child's participation in the rehabilitation process. The exercises were planned such as; the dwarf camel game as squat exercises; the flamingo balance game as single leg balance exercises and weight-bearing activities etc. The exercise program will be conducted for 6 weeks and 3 sessions in a week.
Study NCT05837247 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home exercises
Description: The physiotherapist will evaluate the control group patients and monitor them using only a home exercise program.
Study NCT04825587 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.
Description: By randomizing patients into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone, following statistical analysis, we hope to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.
Study NCT05040542 — intervention group
Intervention type: OTHER
Intervention: maternal exposure during pregnancy
Description: maternal exposure during pregnancy (e.g., environmental exposures and maternal inflammatory states)
Study NCT06159127 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMART@Home
Description: Daily medication and diary completion reminders are provided to participants. Additional educational content regarding self-management skills will be provided.
Study NCT05135975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: Enrolled patients will be treated with cabozantinib maleate, tablet formulation, using the recommended Phase 2 dose of 40 mg/m2/day to a maximum of 420 mg/week. Treatment will be administered in 28- day cycles.
Study NCT05501444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical antiperspirant
Description: The participants will be instructed to use topical antiperspirant (aluminum chloride, 15 percent every evening for four weeks. The PI will contact the participants every week. If the participant experiences that antiperspirant have an effect, the use of antiperspirant will be reduced from daily use to 3 times a week.
Study NCT04971837 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) powder formulation
Description: T-P-S-10 Caliper powder - 30 mg CBD in the form of 300 mg of 10% CBD isolate (Formulation 725: Water soluble.Contains sorbitol)
Study NCT04936139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art Therapy
Description: During the 12 planned sessions, different artistic disciplines will be used: visual arts, music, play, narrative, dramatization, movement and body expression.~Each session is structured in 3 phases:~i. A first part of encounter and contextualization, to make contact with oneself, with the art therapist and with the group through a relaxation or meditation activity (35 minutes).~ii. A second part, where the session continues with the work of artistic elaboration and production with the different materials and the different artistic languages (50 minutes).~iii. A third part where the participants will be invited to make a closing, a moment to welcome and share whoever wishes, the experiences that have been experienced. A dialogue is created between Work-Patient-Art Therapist (35 minutes).
Study NCT05065346 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT
Description: An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.